NLS Pharmaceutics AG

    NLS Pharmaceutics AG

    NNASDAQ:NLSPW
    - -
    USD
    - -
    - -
    NLS Pharmaceutics AG
    NASDAQ:NLSPW
    (Nasdaq Stock Market)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    ILS
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Tangible Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic Weighted Avg Shares
    - -
    - -
    1
    2
    1
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    -6,311.67
    -4,823.53
    -1,500.1
    -1,137.35
    -3,046.35
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    1
    1
    1
    1
    1
    - -
    1
    2
    2
    2
    2
    2
    Depreciation Expense
    -13
    -15
    -17
    -20
    -21
    -24
    -25
    -22
    -26
    -23
    -12
    -27
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    -5,255.83
    -4,703.1
    -1,659.92
    -1,172.81
    -3,132.75
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    -3
    -8
    3
    5
    -15
    -11
    13
    -3
    -7
    -30
    Working Capital
    - -
    - -
    - -
    2
    - -
    - -
    2
    1
    - -
    2
    1
    - -
    LT Debt
    - -
    2
    -1
    -9
    4
    7
    -12
    -8
    15
    - -
    -4
    -29
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    ILS

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    ILS

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    ILS

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    -109.14%
    -258.11%
    568.49%
    Free Cash Flow
    -3.92%
    -25.35%
    -75.01%
    Net Income, GAAP
    12.12%
    13.6%
    121.1%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    ILS

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    ILS

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    ILS

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    - -
    2024
    - -
    - -
    - -
    - -
    - -
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business